Périodique
Screening for co-occuring mental disorders in drug treatment populations
(Repérage des troubles mentaux concomitants dans les populations toxicomanes en soins)
Auteur(s) :
MAGRUDER K. M. ;
SONNE, S. C. ;
BRADY, K. T. ;
QUELLO, S. ;
MARTIN, R. H.
Année
2005
Page(s) :
593-605
Langue(s) :
Anglais
Refs biblio. :
14
Domaine :
Plusieurs produits / Several products
Thésaurus mots-clés
COMORBIDITE
;
TDAH
;
PSYCHIATRIE
;
DEPISTAGE
;
TEST
;
QUESTIONNAIRE
Thésaurus géographique
AMERIQUE DU NORD
Note générale :
Journal of Drug Issues, 2005, 35, (3), 593-605
Note de contenu :
tabl.
Résumé :
ENGLISH :
Substance abuse treatment organizations are universally faced with the problem of co-occurring psychiatric disorders among the clients they serve. A first step is assessment of such comorbid conditions; however, the time constraints in front-line substance abuse treatment organizations make extensive clinical assessments almost impossible. The development and validation of a brief screening tool for psychiatric disorders in individuals with substance use disorders (SUDs) could have enormous implications for clinical practice. We assessed the performance characteristics of the Psychiatric Diagnostic Screening Questionnaire (PDSQ) and the Conners' Adult ADHD Rating Scale (CAARS) against the Structured Clinical Interview for DSM-IV (SCID-IV) in 120 patients admitted to SUD treatment. Patients were randomly assigned to receive either the SCID or PDSQ. In general, the PDSQ and CAARS performed well. There were no statistically significant performance differences by order of administration, gender, or drug use in past month. For the GAD subscale, Caucasian patients had higher levels of agreement than non- Caucasian patients.. (Author's abstract.)
Affiliation :
V.A. Med. Ctr, Charleston, SC
Etats-Unis. United States.
Etats-Unis. United States.
Historique